Precision and Future Medicine

Comparison of survival outcomes between de novo and recurrent stage IV gastric cancers: A retrospective cohort study: Jun Ho Ji, Kwang Min Kim, Byung Soo Kwan, Sung Kim, Yong Seok Kim, Seong Hee Choi, Mi Hyeon Jin, Boo Young Ha, Jinah Kim, Jeff Liang, Naomy Kim, Dan bi Lee, Ju Dong Yang; Precis Future Med. 2023;7(2):74-82. Published online June 30, 2023; DOI: https://doi.org/10.23838/pfm.2023.00051

Combined biomarker for prediction of response to an immune checkpoint inhibitor in metastatic gastric cancer: You Jeong Heo, So Young Kang, Seung Tae Kim, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim; Precis Future Med. 2019;3(4):165-175. Published online December 11, 2019; DOI: https://doi.org/10.23838/pfm.2019.00079
Web of Science 4 Crossref 4

Results from the safety interim analysis of the adjuvant chemoradiotherapy in stomach tumors 2 trial: a multicenter, randomized phase III clinical trial: Se Hoon Park, Jeeyun Lee, Tae Sung Sohn, Do Hoon Lim, Kyoung-Mee Kim, Ji Yeong An, Min Gew Choi, Jun Ho Lee, Jae Moon Bae, Sung Kim, Su Jin Lee, Seung Tae Kim, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang; Precis Future Med. 2019;3(1):24-29. Published online March 13, 2019; DOI: https://doi.org/10.23838/pfm.2018.00177
Web of Science 2 Crossref 2

Reproduction of Gastric Cancer Prognostic Score by real-time quantitative polymerase chain reaction assay in an independent cohort: Kyoung-Mee Kim, Jeeyun Lee, Se Hoon Park, You Jeong Heo, Ji Ryun Jang, Seungtae Kim, Joon Oh Park, Won Ki Kang, Dakeun Lee, Sang-Uk Han, Ji Young An, Min Gew Choi, Tae Sung Sohn, Jae Moon Bae, Sung Kim; Precis Future Med. 2018;2(1):27-32. Published online December 28, 2017; DOI: https://doi.org/10.23838/pfm.2017.00205
Web of Science 2 Crossref 2

Biomarkers for gastric cancer: molecular classification revisited: Jeeyun Lee, Kyoung-Mee Kim; Precis Future Med. 2017;1(2):59-68. Published online June 30, 2017; DOI: https://doi.org/10.23838/pfm.2017.00079
Web of Science 20 Crossref 21

Search